Express Pharma

Johnson & Johnson’s blood cancer therapy gets US FDA approval

J&J's teclistamab, branded as Tecvayli, is approved for treating adults with multiple myeloma that is hard to treat, or has come back after receiving four or more prior lines of certain classes of therapies

0 218